B+
Bull case
20%
Probability
Target price
$19.63
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
GLSI
Greenwich LifeSciencesDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
GLSI offers asymmetric clinical upside if FLAMINGO-01 data continue to support GLSI-100 and the company advances enrollment, manufacturing, and regulatory readiness. The Phase III program and preliminary open-label data provide genuine event-driven upside, but the evidence remains preliminary [#SEC-10Q-2026-06-04] [#PR-2026-03-17].
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta -1.1.
What can break
Dependence on third-party manufacturers for clinical-trial materials creates execution and supply risk [#SEC-10Q-2026-06-04].
Momentum
15
Value
41
Sentiment
48
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $12.73 · Bull $19.63 · Bear $8.78Analysis 2026-08-04; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-04 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $57.00
Why
Momentum15 · Δ7d -0.8
Value41 · Δ7d 0.0
Sentiment48 · Δ7d -1.1
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta -1.1.
Contradictions & invalidation
- • Dependence on third-party manufacturers for clinical-trial materials creates execution and supply risk [#SEC-10Q-2026-06-04].
- • FLAMINGO-01 efficacy, event accrual, interim timing, and regulatory outcomes remain uncertain.
- • The company has no revenue, reported a $5.7 million first-quarter net loss, used $4.7 million in operating cash, and stated that substantial doubt exists about continuing as a going concern without additional capital.
Catalyst clock
2026-09-17
Additional FLAMINGO-01 open-label data
Lead driver: Sentiment · See AI snapshot
Momentum
15
9% active weight
Current posture
7d trendImproving
Δ7d
-0.8
Δ21d
+9.4
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
48
62% active weight
Current posture
7d trendSoftening
Δ7d
-1.1
Δ21d
+10.5
Why this grade
Composite grade D. Momentum 14.5 / Value 41.2 / Sentiment 47.9
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-04. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$12.73
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$8.78
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$255.11M
Beta
1.45
Shares Out
14.68M
P/E (TTM) · Derived
-12.2
P/S (TTM)
-
P/FCF (TTM) · Derived
-19.90
Rev YoY
-
EPS YoY
-3.7%
Gross Margin
-
Op Margin
-
Net Debt
-$6.18M
Current Ratio
1.54
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data